News

Researchers found that targeting gut microbiome dysfunction in a mouse model of DMD improves muscle health and function.

A new cell therapy called MyoPAXon has entered early testing in patients with Duchenne muscular dystrophy.

Early research indicates the therapy could restore nearly 70% of healthy dystrophin protein in people with DMD caused by nonsense mutations.

A new wearable “soft exosuit” developed by researchers in Korea may help people with DMD lift their arms and shoulders.

QMUS is a useful tool that correlates with some aspects of a patient’s functional capacity.

Utilization and costs of novel DMD therapies has risen rapidly in recent years, raising questions about affordability and equitable access

Patients with Duchenne muscular dystrophy may benefit from a potential therapy now supported by an FDA orphan designation.

The ability to keep the torso upright, known as trunk control, might decline even while boys with DMD are still able to walk

Half of boys with Duchenne muscular dystrophy had vertebral fractures, many of which happened silently without obvious trauma.

Transaminitis with no signs of liver dysfunction may signal DMD long before visible weakness or motor delays present, study suggests.